Goodwin to manufacture ADC for Aspyrian 10-Jun-2015 By Zachary Brennan Aspyrian Therapeutics has selected CDMO Goodwin Biotechnology to complete process development, scale-up, and cGMP manufacturing of their novel antibody drug conjugate (ADC).